HOW MUCH SHOULD A HEALTH SYSTEM PAY FOR HEALTH IMPROVEMENTS? — ALIGNING POPULATION PREFERENCES AND BUDGETARY CONSTRAINTS (Q3178166): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location)
(‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates)
Property / contained in NUTS
 
Property / contained in NUTS: Gran Canaria / rank
 
Normal rank

Revision as of 20:48, 10 October 2021

Project Q3178166 in Spain
Language Label Description Also known as
English
HOW MUCH SHOULD A HEALTH SYSTEM PAY FOR HEALTH IMPROVEMENTS? — ALIGNING POPULATION PREFERENCES AND BUDGETARY CONSTRAINTS
Project Q3178166 in Spain

    Statements

    0 references
    119,306.0 Euro
    0 references
    140,360.0 Euro
    0 references
    85.0 percent
    0 references
    26 November 2019
    0 references
    25 November 2022
    0 references
    UNIVERSIDAD DE LAS PALMAS DE GRAN CANARIA
    0 references

    28°7'43.93"N, 15°26'5.64"W
    0 references
    35016
    0 references
    LOS ANALISIS DE COSTE EFECTIVIDAD (ACE) PROPORCIONAN UN MARCO PARA COMPARAR LOS COSTES Y LOS RESULTADOS EN SALUD DE TECNOLOGIAS SANITARIAS ALTERNATIVAS. EL PRINCIPAL OBJETIVO DE LOS ACE ES MEJORAR LA EFICIENCIA DEL SISTEMA SANITARIO Y MAXIMIZAR LAS GANANCIAS EN SALUD DE LA POBLACION CON LOS RECURSOS DISPONIBLES. SIN EMBARGO, PARA PODER REALIZAR UNA RECOMENDACION DE ADOPCION O RECHAZO EN BASE AL CRITERIO DE COSTE-EFECTIVIDAD, NECESITAMOS CONOCER CUANTO ESTA DISPUESTO Y ES CAPAZ EL SISTEMA DE INVERTIR COMO MAXIMO POR UNIDAD EN SALUD GENERADA. EL MARCO ACTUAL DE INVESTIGACION DISPONIBLE NO HA FACILITADO LA FIJACION DE UMBRALES DE COSTE-EFECTIVIDAD, DEBIDO EN PARTE A LA CONTROVERSIA QUE SE MANTIENE EN TORNO AL USO DE UN UMBRAL, A LO QUE ESTE DEBE REPRESENTAR Y A LA METODOLOGIA MAS APROPIADA PARA ESTIMARLO. _x000D_ CONTINUANDO CON EL TRABAJO PREVIO LIDERADO POR LA CANDIDATA A INVESTIGADORA PRINCIPAL, EL OBJETIVO DE ESTE PROYECTO ES CONTESTAR A CADA UNA DE ESTAS CUESTIONES, Y PROPORCIONAR UN MARCO QUE COMBINE DOS PERSPECTIVAS CONCEPTUALES QUE HAN SIDO CONSIDERADAS HASTA AHORA UNICAMENTE EN SOLITARIO. MIENTRAS QUE MUCHOS RECLAMAN QUE EL UMBRAL DEBE REFLEJAR LA VALORACION MONETARIA QUE LA SOCIEDAD LE OTORGA A LA SALUD, OTROS ABOGAN POR QUE EL UMBRAL SE BASE EN EL COSTE DE OPORTUNIDAD RESULTANTE DE LA DESINVERSION REQUERIDA PARA GENERAR RECURSOS PARA UNA NUEVA TECNOLOGIA. LA PRIMERA IDEA TRATA DE INCORPORAR LAS PREFERENCIAS DE LA POBLACION EN LA TOMA DE DECISIONES Y HA SIDO EL CENTRO DE EXTENSAS INVESTIGACIONES EMPIRICAS, MIENTRAS QUE LA SEGUNDA IDEA ESTA FUNDAMENTADA EN LA CONSIDERACION DE LAS RESTRICCIONES PRESUPUESTARIAS A LAS QUE SE ENFRENTAN LOS DECISORES Y HA SIDO ENFATIZADA RECIENTEMENTE EN LA LITERATURA. _x000D_ EL PROYECTO CONSISTIRA EN EL DESARROLLO DE TRES TAREAS: I) DESARROLLAR UN MARCO TEORICO QUE COMBINE LAS DOS PERSPECTIVAS CONCEPTUALES EN TORNO AL UMBRAL, Y EN BASE A ESE MARCO TEORICO: II) DESARROLLAR UN MARCO EMPIRICO FACILMENTE ACTUALIZABLE, TRANSPARENTE Y CON ALCANCE INTERNACIONAL PARA MEDIR EL COSTE DE OPORTUNIDAD DE LAS DECISIONES DE FINANCIACION, Y III) DESARROLLAR UN MARCO EMPIRICO FACILMENTE ACTUALIZABLE, TRANSPARENTE Y CON ALCANCE INTERNACIONAL PARA MEDIR LA VALORACION SOCIAL DE GANANCIAS EN SALUD. ESTE PROYECTO ABORDARA CUESTIONES CONCEPTUALES Y METODOLOGICAS DE ALTA RELEVANCIA A TRAVES DE UNA INVESTIGACION MULTIDISCIPLINAR DE FRONTERA PARA PROPORCIONAR UN MARCO PIONERO QUE PUEDA FINALMENTE POSIBILITAR QUE LA EVIDENCIA SOBRE COSTE-EFECTIVIDAD INFORME LA TOMA DE DECISIONES SANITARIAS. (Spanish)
    0 references
    COST-EFFECTIVENESS ANALYSIS (CEA) PROVIDES A FRAMEWORK TO COMPARE COMPETING HEALTH CARE ALTERNATIVES IN TERMS OF BOTH THEIR HEALTH OUTCOMES AND COSTS. THE PRIMARY OBJECTIVE OF CEA IS TO ENHANCE EFFICIENCY IN THE USE OF HEALTH CARE RESOURCES AND TO MAXIMISE TOTAL HEALTH GAINS IN A POPULATION GIVEN AVAILABLE FUNDS. HOWEVER, IN ORDER TO MAKE FUNDING OR OTHERWISE RECOMMENDATION ON THE BASIS OF COST-EFFECTIVENESS, THE MAXIMUM AMOUNT A SYSTEM IS WILLING AND ABLE TO PAY FOR HEALTH GAINS NEEDS TO BE KNOWN. CURRENT RESEARCH FRAMEWORK HAVE NOT FACILITATED THE ADOPTION OF SPECIFIC COST-EFFECTIVENESS THRESHOLDS, PARTLY DUE TO THE CONTROVERSY THAT REMAINS AROUND THE USE OF A THRESHOLD, ABOUT WHAT THE THRESHOLD OUGHT TO REPRESENT AND ABOUT THE APPROPRIATE METHODOLOGY TO ARRIVE AT A THRESHOLD VALUE._x000D_ BUILDING ON THE PREVIOUS WORK LED BY THE PI CANDIDATE, THE AIM OF THIS RESEARCH PROJECT IS TO ADDRESS EACH OF THESE ISSUES AND TO PROVIDE A FRAMEWORK THAT INCORPORATES TWO CONCEPTUAL PERSPECTIVES THAT HAVE SO FAR ONLY BEEN CONSIDERED IN ISOLATION. WHILE SOME AUTHORS CLAIM THAT THE THRESHOLD SHOULD REFLECT SOCIETY¿S MONETARY VALUATION OF HEALTH, OTHERS ADVOCATE FOR IT TO BE BASED ON THE OPPORTUNITY COST RESULTING FROM THE DISINVESTMENT REQUIRED TO ADOPT A NEW TECHNOLOGY. THE FORMER VIEW AIMS TO INCORPORATE POPULATION¿S PREFERENCES IN DECISION-MAKING AND HAS BEEN THE FOCUS OF EXTENSIVE EMPIRICAL RESEARCH, WHILE THE LATTER IS GROUNDED ON ACCOUNTING FOR BUDGET CONSTRAINTS FACED BY DECISIONS MAKERS AND HAS JUST RECENTLY BEEN EMPHASISED IN THE EMPIRICAL LITERATURE. _x000D_ THREE TASKS WILL BE UNDERTAKEN IN THIS PROJECT: I) DEVELOPING A THEORETICAL FRAMEWORK INCORPORATING THE TWO CONCEPTUAL PERSPECTIVES ON THE THRESHOLD ANALYSIS, AND BASED ON SUCH FRAMEWORK: II) DEVELOPING AN UPDATEABLE, TRANSPARENT AND INTERNATIONALLY RELEVANT EMPIRICAL FRAMEWORK FOR THE MEASUREMENT OF THE OPPORTUNITY COST OF HEALTH CARE FUNDING DECISIONS, AND III) DEVELOPING AN UPDATABLE, TRANSPARENT AND INTERNATIONALLY RELEVANT EMPIRICAL FRAMEWORK FOR THE MEASUREMENT OF THE SOCIETAL MONETARY VALUATION OF HEALTH GAINS. THIS WORK WILL ADDRESS SIGNIFICANT CONCEPTUAL AND METHODOLOGICAL ISSUES INVOLVING MULTIDISCIPLINARY FRONTIER RESEARCH TO PROVIDE A GROUND-BREAKING FRAMEWORK WITH INTERNATIONAL APPEAL THAT CAN READILY ENABLE COST-EFFECTIVENESS EVIDENCE TO INFORM DECISION MAKING. (English)
    0 references
    Palmas de Gran Canaria, Las
    0 references

    Identifiers

    RTI2018-096365-J-I00
    0 references